Bladder Cancer
Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit.
August 14, 2024
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
August 13, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.
August 12, 2024
Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females.
August 12, 2024
Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features.
August 9, 2024
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer.
August 8, 2024
Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B).
August 8, 2024
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.
August 8, 2024
Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer.
August 7, 2024
Efficacy of Gemcitabine and Docetaxel for Treatment of Micropapillary Urothelial Carcinoma - Expert Commentary
August 6, 2024